SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-21-000039
Filing Date
2021-03-04
Accepted
2021-03-04 16:00:21
Documents
3
Period of Report
2021-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm8-kq4pr_fy2020.htm 8-K 25281
2 EX-99.1 exhibit991q4pressrelease_1.htm EX-99.1 87649
3 evofembiosciencesjpegfileaa.jpg GRAPHIC 61097
  Complete submission text file 0001618835-21-000039.txt   198272
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 21714059
SIC: 2834 Pharmaceutical Preparations